SMTL ID : 8rrq.1

Crystal structure of human SYK in complex with compound 24

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x 01: N-[(1S,2R)-2-azanylcyclohexyl]-5-[2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl]-2-methyl-pyrazole-3-carboxamide

01.1: 25 residues within 4Å: Chain A: L.24, G.25, S.26, G.27, F.29, V.32, A.47, K.49, E.67, V.80, L.93, M.95, E.96, M.97, A.98, E.99, L.100, G.101, P.102, R.145, N.146, L.148, S.158, D.159, F.160 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.24, A:L.148 Hydrogen bonds: A:A.98, A:A.98, A:D.159 Water bridges: A:D.159, A:D.159

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 3 residues within 4Å: Chain A: D.169, E.170, Y.172 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cervi, G. et al., Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitors. Eur.J.Med.Chem. (2024)

Release Date

2024-04-24

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence